(Q44080105)

29 November 2017

Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori (English)

1 reference

29 November 2017

0 references

1 reference

1 reference

Brian Sullivan

1

1 reference

29 November 2017

Walter Coyle

series ordinal

2

1 reference

29 November 2017

Richard Nemec

series ordinal

3

1 reference

29 November 2017

Thomas Dunteman

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

The American Journal of Gastroenterology

29 November 2017

1 reference

29 November 2017

97

1 reference

29 November 2017

10

1 reference

29 November 2017

2536-2539

1 reference

Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States

29 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.06036.X

Antibiotic resistance problems with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.06036.X

Low- versus high-dose azithromycin triple therapy for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.06036.X

Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.06036.X

A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.06036.X

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.06036.X

10.1111/J.1572-0241.2002.06036.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference